Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Growth

    Back to All Ratios
AARTI PHARMALABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 13.5264.41--

What is the latest Core EBITDA Growth ratio of AARTI PHARMALABS ?

The latest Core EBITDA Growth ratio of AARTI PHARMALABS is 13.52 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202413.52
Mar202364.41
Mar2022-
Mar2021-

How is Core EBITDA Growth of AARTI PHARMALABS Trending?

Years Core EBITDA Growth % Change
Mar2024 13.52
-79.01
Mar2023 64.41
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Growth ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹8,061.1 Cr 1.1% 25.8% 59.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,865.0 Cr -0.5% -8.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹173,574.0 Cr -2.4% 7.2% 50.6% Stock Analytics
CIPLA ₹118,710.0 Cr -0.7% -3.7% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,964.0 Cr -1.4% -3.9% 19% Stock Analytics
DR REDDYS LABORATORIES ₹104,232.0 Cr 0.5% 5.6% 5.1% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

1.1%

25.8%

59.4%

SENSEX

-1%

1.4%

7.9%


You may also like the below Video Courses